Oncopharmpod
BRAF V600E Updates
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:16:30
- More information
Informações:
Synopsis
Encorafenib + binimetinib gets FDA-approval for metastatic NSCLC, but how does it compare to dabrafenib/trametinib? Plus, a new pediatric approval for dabrafenib/trametinib means more dosage form options.
